IMBdx

IMBdx Share · KR7461030009 (XKOS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of IMBdx
No Price
Closing Price XKOS 30.04.2026: 6.960,00 KRW
30.04.2026 06:30
Current Prices from IMBdx
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
461030.KQ
KRW
30.04.2026 06:30
6.960,00 KRW
-
Share Float & Liquidity
Free Float 37,00 %
Shares Float 5,19 M
Shares Outstanding 14,02 M
Company Profile for IMBdx Share
IMBdx, Inc. engages in the development of liquid biopsy tests for cancer diagnosis. It focuses on the following business areas: diagnosis and treatment of advanced cancer, early detection of recurrence after surgery, and early cancer diagnosis. Its products include AlphaLiquid, CancerDetect, and CancerFind. The company was founded by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018 and is headquartered in Seoul, South Korea.

Company Data

Name IMBdx
Company IMBdx
Website http://www.imbdx.com
Primary Exchange XKOS KOSDAQ
ISIN KR7461030009
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Tae-You Kim
Market Capitalization 98 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address BYC Highcity Bldg A, Seoul
IPO Date 2024-04-01

Ticker Symbols

Name Symbol
KOSDAQ 461030.KQ
More Shares
Investors who hold IMBdx also have the following shares in their portfolio:
A SPAC III Acquisition Corp. - Class A Ordinary Shares
A SPAC III Acquisition Corp. - Class A Ordinary Shares Share
WESTP.SEC.NZ 23/28 MTN
WESTP.SEC.NZ 23/28 MTN Bond